Tuesday, October 4, 2022

OncoSec Slashes Staff By Near Half

San Diego- and Pennington, New Jersey-based OncoSec Medical said on Tuesday that it is slashing its staff by nearly half, as part of a "pipeline prioritization" as the company looks to extend its cash runway. The publicly traded company--which trades on the NASDAQ as ONCS--said it is cutting its staff by approximately 45%, and will now focus on its activites in the area of melanoma, to meet near-term data milestones.